Registration Header Parameters

Normalized identity and public registration information from FDA records.

Source

FDA Device Registration & Listing

Record Type

Device registration/listing

Registration Number

3015745144

FEI Number

3015745144

Entity Name

REDISTON LTD.

City/State/Country

-, HK

Establishment Address

Level 15 Nexxus Building 41 Connaught Road Central, - -, HK

Establishment Type(s)

Export Device to the United States But Perform No Other Operation on Device

Owner / Operator

Rediston Ltd. (Owner Number: 10060989)

Owner / Operator Contact Address

Level 15 Nexxus Building, 41 Connaught Road, Central, HK-NOTA -, HK

Initial Importer Flag

Expiration Date (Year)

2026

510(k) Number

N/A

PMA Number

N/A

All Registered Proprietary Names

No proprietary names listed under this establishment.

Registered Product Listings

Product Code	Device Name	Medical Specialty	Device Class	Regulation Number	Created Date
JIN	Nitroprusside, Ketones (Urinary, Non-Quant.)	Clinical Chemistry	Class 1	862.1435	2019-07-25

Official Correspondent

No official correspondent registered.

US Agent Details

David Lennarz Business: Registrar Corp Email: david.lennarz@registrarcorp.com Phone: (757) 2240177

Related Public Records

Same Entity

Rediston Ltd.

View consolidated registration, premarket clearance, and recall records for this applicant.

View Entity Profile →

Similar Registrations

Registration Number	Establishment Name	Location
3014353121	VIDAN DIAGNOSTICS, LLC	San Antonio, TX, US
1649661	GERMAINE LABORATORIES, INC.	SAN ANTONIO, TX, US
3002637618	Siemens Healthcare Diagnostics Inc	East Walpole, MA, US
3008517993	ZHEJIANG ORIENT GENE BIOTECH	Huzhou Zhejiang, CN
3004193489	NOVA BIOMEDICAL CORPORATION DIABETES PRODUCTS	Billerica, MA, US

Source Citation & Summary: This public preview is extracted from openFDA device registration and listing logs under registration number 3015745144. Last updated year: 2026. Please use registration number 3015745144 when referencing this establishment in official correspondence.